Literature DB >> 16275343

Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates.

Alexei F Kisselev1, Alfred L Goldberg.   

Abstract

Eukaryotic proteasomes have three different types of active sites: two chymotrypsin-like, two trypsin-like, and two caspase-like (also termed PGPH) sites that differ in their specificity toward model fluorogenic peptide substrates. The chymotrypsin-like site is often considered the most important in protein breakdown, and the only one whose activity has to be assayed in order to assess the capacity of proteasomes to degrade proteins. However, recent results indicate that either trypsin-like or caspase-like sites also have to be inhibited in order to reduce breakdown of most proteins by 50%. Thus, the activities of all three types of active sites have to be assayed in order to evaluate the state of the proteasome inside cells or the potency of inhibitors. This chapter describes assays of purified 26S proteasomes with fluorogenic peptide substrates, including new substrates of the caspase- and trypsin-like sites. A novel assay of proteasome activity in crude cell extracts that allows rapid evaluation of the state of the proteasomes in cells treated with inhibitors is also described.

Mesh:

Substances:

Year:  2005        PMID: 16275343     DOI: 10.1016/S0076-6879(05)98030-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  151 in total

1.  SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.

Authors:  Pablo Garcia-Reitböck; Oleg Anichtchik; Arianna Bellucci; Mariangela Iovino; Chiara Ballini; Elena Fineberg; Bernardino Ghetti; Laura Della Corte; PierFranco Spano; George K Tofaris; Michel Goedert; Maria Grazia Spillantini
Journal:  Brain       Date:  2010-06-09       Impact factor: 13.501

2.  The origin of proteasome-inhibitor resistant HLA class I peptidomes: a study with HLA-A*68:01.

Authors:  Noel García-Medel; Alejandro Sanz-Bravo; Eilon Barnea; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2011-10-03       Impact factor: 5.911

3.  Proteasome activity correlates with male BMI and contributes to the differentiation of adipocyte in hADSC.

Authors:  Kozue Sakamoto; Youichi Sato; Masako Sei; Ashraf A Ewis; Yutaka Nakahori
Journal:  Endocrine       Date:  2010-01-05       Impact factor: 3.633

4.  Self-Incompatibility Triggers Irreversible Oxidative Modification of Proteins in Incompatible Pollen.

Authors:  Tamanna Haque; Deborah J Eaves; Zongcheng Lin; Cleidiane G Zampronio; Helen J Cooper; Maurice Bosch; Nicholas Smirnoff; Vernonica E Franklin-Tong
Journal:  Plant Physiol       Date:  2020-04-22       Impact factor: 8.340

5.  Inhibition of proteasome activity impairs centrosome-dependent microtubule nucleation and organization.

Authors:  Christine Didier; Andreas Merdes; Jean-Edouard Gairin; Nabila Jabrane-Ferrat
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

6.  Three calpain isoforms are autolyzed in rat fast-twitch muscle after eccentric contractions.

Authors:  Keita Kanzaki; Mai Kuratani; Satoshi Matsunaga; Noriyuki Yanaka; Masanobu Wada
Journal:  J Muscle Res Cell Motil       Date:  2014-02-21       Impact factor: 2.698

7.  UBL domain of Usp14 and other proteins stimulates proteasome activities and protein degradation in cells.

Authors:  Hyoung Tae Kim; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-28       Impact factor: 11.205

8.  Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated ERK activation in response to lipopolysaccharide.

Authors:  Suraj Dhungana; B Alex Merrick; Kenneth B Tomer; Michael B Fessler
Journal:  Mol Cell Proteomics       Date:  2008-09-23       Impact factor: 5.911

9.  Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11.

Authors:  Jing Li; Yaru Zhang; Bruno Da Silva Sil Dos Santos; Feng Wang; Yuyong Ma; Christian Perez; Yanling Yang; Junmin Peng; Seth M Cohen; Tsui-Fen Chou; Stephen T Hilton; Raymond J Deshaies
Journal:  Cell Chem Biol       Date:  2018-08-23       Impact factor: 8.116

10.  Cancer vulnerabilities unveiled by genomic loss.

Authors:  Deepak Nijhawan; Travis I Zack; Yin Ren; Matthew R Strickland; Rebecca Lamothe; Steven E Schumacher; Aviad Tsherniak; Henrike C Besche; Joseph Rosenbluh; Shyemaa Shehata; Glenn S Cowley; Barbara A Weir; Alfred L Goldberg; Jill P Mesirov; David E Root; Sangeeta N Bhatia; Rameen Beroukhim; William C Hahn
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.